Group items tagged

The CDC released travel health notices Tuesday that named two more places in which the disease has spread via mosquito bites: The US Virgin Islands and the Dominican Republic.  The Zika virus is primarily transmitted by Aedes aegypti, the type of mosquito responsible for spreading dengue, yellow fever, and a whole host of other tropical infectious diseases. Originally identified in 1947 in Uganda, Zika was relatively unknown until 2007, when there was an outbreak of the virus in Micronesia. The mosquitoes pick up the virus from infected people, according to the CDC. 

This case study was inspired by the Zika virus outbreak that occurred around the time of the 2016 Olympic Games. Many athletes were fearful of attending because of the link between Zika virus infection and microcephaly in infants. This concern, however, ran contrary to reports suggesting that the risk of athletes and other travelers becoming infected was remarkably low. Jessica, a fictional Olympic equestrian and the main character of the case, was unfortunately very unlucky and contracted Zika virus near the time of the Games. She ended up enduring negative health complications likely as a consequence of the infection.  This case was designed to be implemented in the nervous system unit of a human biology or anatomy and physiology course. The case is also appropriate for microbiology and public health courses.   Students are expected to have foundational knowledge in viral life cycles, and will explore disruptions in neurotransmission as well as abnormal fetal brain development.

U.S. researchers have found that Zika can attack special populations of brain cells in adult mice in the part of the brain involved in learning and memory, raising new questions about how the virus may be impacting millions of adults who have been infected with the virus. The findings, published on Thursday in the journal "Cell Stem Cell," are the first to look at whether Zika can attack the same kinds of cells in adult mice that they do in fetal mice.

Scientists and healthcare professionals initially exhibited little concern over the Zika virus even after evidence of human infection was first identified in 1952; Zika appeared to be both rare and unassociated with morbidity or mortality. Around 2015 all of this changed as journalists, scientists, public health officials, and laypeople scrambled to learn about its varied modes of transmission and devastating consequences (e.g., birth defects and autoimmune disorders). Although research continues to rapidly evolve, this case study directs students to reliable scientific sources (e.g., Centers for Disease Control and World Health Organization) that will likely continue to provide the most current information in order to explore questions such as: Where did the virus come from? How does it spread? What can we do to prevent it? Students will also consider the public health challenges and possible solutions associated with emerging infectious diseases. The case was originally written for an upper-level biology or public health course in which students already have some basic background knowledge regarding viruses, vaccines, and infectious disease.

Throughout the last few decades, diseases that spill over from animals to humans have been on the rise. What's behind their increase, and can we do anything to combat these dangerous foes? Join scientists as they investigate the rise of spillover viruses like Zika, Ebola and Nipah, and learn what science can do to anticipate and prevent epidemics around the world.

Some tiny clusters of brain cells grown in a lab dish are making big news at this week's Society for Neuroscience meeting in San Diego. Known as "minibrains," these rudimentary networks of cells are small enough to fit on the head of a pin, but already are providing researchers with insights into everything from early brain development to Down syndrome, Alzheimer's and Zika.

In both cases, researchers found that ZIKV-177 reduced levels of Zika virus in pregnant mice and their fetuses, compared with pregnant mice that were not given the antibody.